1. Home
  2. ETON vs WEAV Comparison

ETON vs WEAV Comparison

Compare ETON & WEAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eton Pharmaceuticals Inc.

ETON

Eton Pharmaceuticals Inc.

HOLD

Current Price

$17.61

Market Cap

411.9M

Sector

Health Care

ML Signal

HOLD

Logo Weave Communications Inc.

WEAV

Weave Communications Inc.

HOLD

Current Price

$5.31

Market Cap

487.7M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ETON
WEAV
Founded
2017
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
411.9M
487.7M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
ETON
WEAV
Price
$17.61
$5.31
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$31.00
$11.00
AVG Volume (30 Days)
293.3K
2.5M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
13.04
EPS
N/A
N/A
Revenue
$39,011,000.00
$204,314,000.00
Revenue This Year
$107.23
$17.29
Revenue Next Year
$29.72
$13.46
P/E Ratio
N/A
N/A
Revenue Growth
23.29
19.85
52 Week Low
$11.09
$4.85
52 Week High
$23.00
$12.31

Technical Indicators

Market Signals
Indicator
ETON
WEAV
Relative Strength Index (RSI) 57.35 39.41
Support Level $17.38 N/A
Resistance Level $20.35 $7.31
Average True Range (ATR) 1.06 0.36
MACD 0.03 0.02
Stochastic Oscillator 41.19 35.63

Price Performance

Historical Comparison
ETON
WEAV

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

About WEAV Weave Communications Inc.

Weave Communications Inc is a customer experience and payments software platform tailored for SMB healthcare businesses, that revolutionizes patient interaction from initial contact to billing. It integrates diverse workflows into a unified solution, minimizing manual tasks and maximizing patient engagement. Weave democratizes enterprise-level communication tools, simplifying them for SMBs in a singular platform. Offering varied communication channels, appointment scheduling, payment processing, and more, enhances practitioner-patient relationships and optimizes practice operations. The company has a singular operating segment and revenue from subscription services.

Share on Social Networks: